NCT03674476View on ClinicalTrials.gov

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

June 24, 2019

Study Completion Date

June 24, 2019

Conditions
NAFLDNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Interventions
DRUG

BMS-986036

Specified dose on specified days

Trial Locations (4)

1077

PRA Magyarorszag Kft, Budapest

1083

Semmelweis Egyetem, Budapest

3529

Clinical Research Unit Hungary, Miskolc

170 00

Pharmaceutical Research Associates CZ, s.r.o, Prague

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY